Justin W. Yorke, Director at Processa Pharmaceuticals, Inc. (PCSA), bought 8,000 shares at $2.69 ($22K) on 2024-01-30, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCSA | SELL | 2021-12-07 | $46K | — | Filing → |
| PCSA | SELL | 2021-04-15 | $220K | — | Filing → |